Lifeward (LFWD) Total Non-Current Liabilities (2014 - 2026)
Lifeward (LFWD) reported Total Non-Current Liabilities of $16.5 million for Q1 2026, up 1186.51% on a YoY basis from $1.3 million in Q1 2025, and up 572.36% sequentially from $2.5 million in Q4 2025.
Lifeward (LFWD) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Lifeward (LFWD) has 13 years of Total Non-Current Liabilities data on file, last reported at $16.5 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 1186.51% year-over-year to $16.5 million; the trailing twelve-month figure through Mar 2026 stood at $16.5 million (up 1186.51% YoY), and the FY2025 full-year result was $2.5 million, up 73.6% from the prior year.
- Total Non-Current Liabilities grew to $16.5 million in Q1 2026, from $2.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $16.5 million in Q1 2026 to a low of $961000.0 in Q3 2022.
- A 5-year average of $3.1 million and a median of $1.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities slumped 71.58% in 2025 and soared 1186.51% in 2026, its largest moves.
- Tracing LFWD's Total Non-Current Liabilities over 5 years: stood at $1.3 million in 2022, then soared by 279.13% to $4.9 million in 2023, then tumbled by 71.09% to $1.4 million in 2024, then soared by 73.6% to $2.5 million in 2025, then soared by 572.36% to $16.5 million in 2026.
- Business Quant data shows LFWD's Total Non-Current Liabilities at $16.5 million in Q1 2026, $2.5 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | 16.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.49 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 4.33 Mn |
| Mar 31, 2024 | 4.51 Mn |
| Dec 31, 2023 | 4.89 Mn |
| Sep 30, 2023 | 4.63 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.58 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 961,000.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 1.19 Mn |
| Dec 31, 2021 | 1.33 Mn |
| Sep 30, 2021 | 1.34 Mn |
| Jun 30, 2021 | 1.43 Mn |